Viloxazine ER for ADHD Reduces Weight Among Adults With Overweight, Obesity
Relative to placebo, Viloxazine extended-release (viloxazine ER) treatment for attention-deficit hyperactivity disorder (ADHD) is associated with significant weight loss – particularly among adults with overweight and/or obesity at baseline. These study results were presented at Psych Congress 2024, held from October 29 to November 2, 2024 in Boston, Massachusetts.
Read MoreFor some elite athletes, neurodivergence can be a super strength
The hyperfocus on tasks that is common with ADHD and autism is a real asset when it comes to sports.
Read MoreWhen It Comes to ADHD in Women, There’s Still So Much to Learn
For girls and women living with attention-deficit/hyperactivity disorder (ADHD), and the clinicians who treat them, there are still more questions than answers regarding how the condition evolves over the lifespan.
Read MoreNew study reinforces the benefits of behavioral therapy first for treating kids with ADHD
Groundbreaking research by ADHD pioneer William E. Pelham, Jr., who passed away last year, found that behavioral therapy – when used first – was less expensive and more effective than medication in treating children with ADHD. Building on this foundation, a new study by Pelham’s team at the FIU Center for Children and Families, published…
Read MoreAre Food Dyes Bad For Your Health?
In September, California became the first state in the nation to ban six artificial food dyes from meals served in public schools. The move followed a 2021 report from the state’s Office of Environmental Health Hazard Assessment (OEHHA) that concluded the body of evidence supported a relationship between food dye exposure and adverse behavioral outcomes…
Read MoreHow I’m learning to navigate academia as someone with ADHD
Discovering how my brain works has helped me to better understand how to find equilibrium between my academic career and my well-being, says Ana Bastos.
Read MoreExperts urge tailored perinatal care for neurodivergent mothers
Research from Edith Cowan University (ECU) has called for greater recognition of the needs of neurodivergent mothers during perinatal care.
Read MoreADHD: Overlooked Cause of Persistent Anxiety and Depression in Adults
Key Takeaways: ADHD in adults is underdiagnosed, often masked by comorbid conditions, leading to significant psychosocial impairments. Accurate diagnosis requires comprehensive history-taking, standardized tools, and functional assessments to differentiate from other psychiatric disorders. ADHD prevalence in adults is 2.5%, with high comorbidity rates with bipolar disorder, major depressive disorder, and substance use disorder. Early identification…
Read MoreDigame: Sara Mendez is Advocating for BIPOC with ADHD
Puerto Rican content creator Sara Mendez empowers and educates on BIPOC with ADHD
Read MoreWhy so many people with ADHD are breaking free from gender norms
Their neurodivergence helped them understand their gender identity—here’s the science behind it.
Read MorePutting community first: ADHD program challenges traditional research paradigms
Each fall, Dr. Emi Furukawa, Group Leader of OIST’s Human Developmental Neurobiology Unit and Children’s Research Center, attends the European Network for Hyperkinetic Disorders’ (EUNETHYDIS) annual meeting, a conference that links a vast network of ADHD researchers, most of whom are based in Europe. Last year, Professor Gail Tripp, head of the unit, presented their…
Read MoreHow fidgeting can help people with ADHD focus
Fidgeting is a common trait of ADHD (attention-deficit/hyperactivity disorder). Whether it’s picking at fingernails or tapping a foot, many people with ADHD tend to move more often than those without the condition.
Read More